|
Pediatric Cardiomyopathy Registry Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Pediatric Cardiomyopathy Registry conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Pediatric Cardiomyopathy Registry Clinical research trials and Pediatric Cardiomyopathy Registry healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Pediatric Cardiomyopathy Registry. Pediatric Cardiomyopathy Registry Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Pediatric Cardiomyopathy Registry clinical trial. Participants typically obtain the most effective healthcare available for their Pediatric Cardiomyopathy Registry condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Pediatric Cardiomyopathy Registry  Pediatric Cardiomyopathy Registry
Pediatric Cardiomyopathy Registry
For Condition: Myocardial Diseases,Cardiovascular Diseases,Heart Diseases
Status: No longer recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To establish and maintain a national registry of children with different forms of cardiomyopathy.
Details: BACKGROUND: Children with cardiomyopathy represent the most dismal outcome of any group of diseases followed by pediatric cardiologists, with up to 40 percent of infants and children with symptomatic cardiomyopathy failing medical or surgical management in the first year following diagnosis. For 57 percent of children with cardiomyopathy, no etiology is known. Although pediatric cardiomyopathy is common, there is considerable variation in its causes. Therefore, for any specific etiology, no center of pediatric cardiology sees a sufficient number of patients to make major advances in understanding this group of diseases. The registry was developed to collect and organize all relevant data on the condition. Data accrued by and reported by the registry should lead to increased awareness and knowledge of pediatric cardiomyopathy and its causes, as well as the development of new diagnostic and therapeutic approaches. DESIGN NARRATIVE: The registry consists of a prospective, population-based cohort of patients in New England and the Central Southwestern United States and a retrospective cohort of patients diagnosed between 1991 and 1996. Annual follow-up data are collected on all patients. Specific hypotheses are that l) during the period of the registry, the percentage of cases that are diagnosed as idiopathic will decrease (i.e., etiologies will be found) and 2) at the time of diagnosis of cardiomyopathy, factors such as gender, ethnicity, age, type of cardiomyopathy, and presence or absence of a syndrome can help predict outcomes. Definition of entry and exclusion criteria, clinical quality assurance, and accrual and retention of participating clinical centers are largely under the direction of the University of Rochester in Rochester, New York and Baylor College of Medicine. Virtually all pediatric cardiology centers in the United States, Puerto Rico, and Canada have expressed their willingness to send patient information to such a registry. The study has been extended through August, 2004.
Eligibility:
Study Type: Observational, Screening
Minimum Age/Maximum Age: /18 Years
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
StevenLipshultz, , University of Rochester
Additional Information:
Study ID Numbers: 4297;
Study Start Date: September 1995
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005391
Other Myocardial Diseases Studies:
1. Epidemiology of Idiopathic Dilated Cardiomyopathy (Washington, DC Dilated Cardiomyopathy Study)
2. AIDS-Associated Heart Disease -- Incidence and Etiology
3. Enalapril After Anthracycline Cardiotoxicity
4. Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States
5. Pediatric Cardiomyopathy Registry
Related Studies:
Other Myocardial Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials
Pediatric Cardiomyopathy Registry
|
|
|
|
|
|
|
|
